Pieter Rutter Cullis

Vancouver, Canada

Pieter Rutter Cullis

Average Co-Inventor Count = 4.5

ph-index = 38

Forward Citations = 5,590(Granted Patents)

Forward Citations (Not Self Cited) = 4,958(Sep 21, 2024)

DiyaCoin DiyaCoin 8.58 

Inventors with similar research interests:



Years Active: 1989-2025

where 'Filed Patents' based on already Granted Patents

72 patents (USPTO):
29 patents (CIPO):

Title: The Innovative Journey of Pieter R Cullis

Introduction: Pieter R Cullis is a renowned inventor hailing from Vancouver, Canada. He has made significant contributions to the field of biotechnology and drug delivery systems, revolutionizing the way medications are administered and enhancing their effectiveness.

Latest Patents: Pieter R Cullis holds several patents related to lipid nanoparticle technology, which have paved the way for the development of novel drug delivery systems. These patents showcase his innovative approach to improving the delivery of therapeutic agents to target cells with precision.

Career Highlights: With a distinguished career spanning several decades, Pieter R Cullis has been at the forefront of research in lipid nanoparticle technology. His groundbreaking work has led to the commercialization of several drug delivery systems that are now used in the treatment of various medical conditions.

Collaborations: Throughout his career, Pieter R Cullis has collaborated with leading researchers, pharmaceutical companies, and academic institutions to further the development of lipid nanoparticle technology. His collaborative efforts have resulted in the successful translation of research findings into practical applications that benefit patients worldwide.

Conclusion: Pieter R Cullis's dedication to innovation and his pioneering work in the field of drug delivery systems have had a profound impact on the healthcare industry. His contributions continue to inspire future generations of inventors and researchers to push the boundaries of science and technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…